Affordable Access

deepdyve-link
Publisher Website

[Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

Authors
  • Janzen, R W C
  • Ludwig, W D
Type
Published Article
Journal
Zeitschrift für Rheumatologie
Publication Date
Feb 01, 2012
Volume
71
Issue
2
Identifiers
DOI: 10.1007/s00393-011-0901-8
PMID: 22370801
Source
Medline
License
Unknown

Abstract

The off-label use of approved pharmaceuticals outside the authorized status is implemented in pharmacotherapy of many diseases, especially for rare diseases and in cases of therapy resistance. The German regulations are presented and analyzed and the relative literature is discussed.

Report this publication

Statistics

Seen <100 times